€737,688
▼ Sales (10 ops.)
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Bedrosian Camille L. Insider active across 4 companies, notably Ultragenyx Pharmaceutical Inc.. Cumulatively, 23 disclosures have been logged. Split: 0 buy · 10 sells. Total volume traded: €738k. Activity tracked since 6 May 2021. The latest transaction was disclosed on 18 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Bedrosian Camille L
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
22,807 shares0Common StockSEC:0001193125-26-359676:0
5,925 sharesCommon StockSEC:0001628280-26-044712:0
95,990 shares0Common StockSEC:0001193125-26-098436:0
6,461 shares@ US$14.580619.4% of flowCommon StockSEC:0001193125-26-091440:0
6,580 shares@ US$14.349324.5% of flowCommon StockSEC:0001193125-25-306818:0
12,039 shares@ US$14.579159.7% of flowCommon StockSEC:0001193125-25-228339:0
4,000 sharesCommon StockSEC:0001104659-25-061711:0
6,900 shares0Common StockSEC:0000950170-25-086265:0
12,425 shares@ US$3.467439.4% of flowCommon StockSEC:0000950170-25-049567:0
68,420 shares0Common StockSEC:0000950170-25-036712:0
5,421 shares@ US$5.535428.1% of flowCommon StockSEC:0000950170-24-132885:0
11,442 shares@ US$3.195232.5% of flowCommon StockSEC:0000950170-24-111809:0
3,000 sharesCommon StockSEC:0001104659-24-074767:0
3,400 shares0Common StockSEC:0000950170-24-071923:0
96,910 shares0Common StockSEC:0000950170-24-045693:0
58,333 shares0Common StockSEC:0000950170-23-066796:0
6,000 shares0Common StockSEC:0001209191-23-038818:0
2,663 shares0Common StockSEC:0001209191-23-016053:0
2,821 shares@ US$66.6237.9% of flowCommon StockSEC:0001209191-22-015802:0
1,657 shares@ US$66.3022.3% of flowCommon StockSEC:0001209191-22-005838:0
359 shares@ US$81.145.7% of flowCommon StockSEC:0001209191-21-060765:0
2,500 shares@ US$55.0026.3% of flowCommon StockSEC:0001209191-21-054542:0
364 shares@ US$113.677.8% of flowCommon StockSEC:0001209191-21-031376:0
About Bedrosian Camille L
Bedrosian Camille L is a declarant associated with Amylyx Pharmaceuticals, Inc., Ultragenyx Pharmaceutical Inc., Crinetics Pharmaceuticals, Inc. and Rhythm Pharmaceuticals, INC. The record shows 22 filings in total, and across the 22 sampled filings from 2021-05-10 to 2026-06-22, sell transactions total 737688 EUR, with the modal transaction nature listed as Cession.